2019 -now Board Member and Acting Chief Creative Officer @
2019 -now Owner @ Smiling Biotech
2016 -2019 Director, Prozyme Europe Aps @
2015 -2016 Emeai Business Team Leader, Seahorse Products @
2009 -2015 European Sales Director @
2008 -2009 International Sales Manager @
2007 -2008 Sales Leader Bio-Discovery Nordic @
2003 -2006 Sales Leader Denmark @
2000 -2003 Account Manager @
1997 -2000 Technical Sales Support @
Hasse Hedeby Education
AVT Business School
(Management)
2002-2003
Aarhus University
Master of Science (Chemistry)
1989-1996
Hasse Hedeby Skills
Biotechnology
Drug Discovery
Lifesciences
Genomics
Biopharmaceuticals
Cell Biology
Protein Purification
Life Sciences
Sales Management
Medical Devices
International Sales
Management
Molecular Biology
Laboratory
Sales Operations
Leadership
Commercialization
Immunology
Immunoassays
Biochemistry
Business Development
Cross-functional Team Leadership
Business Strategy
Sales
Distributors
Account Management
Strategy
Strategic Planning
Product launch
Business Planning
Negotiation
Marketing
Marketing Strategy
Pharmaceutical Industry
Life Science Industry
English
spanish
Cross Functional Team Leadership
Hasse Hedeby Summary
Hasse Hedeby, based in Copenhagen, DK, is currently a Chief Commercial Officer at Fida Biosystems. Hasse Hedeby brings experience from previous roles at Bifrost Biolabs, Smiling Biotech, Prozyme, Inc. and Agilent Technologies. Hasse Hedeby holds a 2002 - 2003 AVT Business School. With a robust skill set that includes Biotechnology, Drug Discovery, Lifesciences, Genomics, Biopharmaceuticals and more. Hasse Hedeby has 2 emails and 1 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.